Sign in or register to see full information and data.

Studies / CAVD 374


Study information

Grant Affiliation:Haynes: B-Cell Lineage Envelope Design
Strategy:Prophylactic neutralizing Ab
Study Type:Antibody Screening
Species:Non-Organism Study
Stage:Assays Completed
Study Start Date:2012-07-06
Study Made Public:2016-01-15


Characterization of monoclonal antibodies from RV144 vaccine recipients


CAVD 374 is an immunogenicity study to identify and characterize monoclonal antibodies from vaccine recipients in the human clinical trial, RV144.


ALVAC (vCP1521) AIDSVAX B/E Saline (non-specific) Placebo ALVAC Placebo AIDSVAX B/E

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.